Author:
Melamed Eldad,Rosenthal Jutta,Cohen Oren,Mordechai Globus,Uzzan Anat
Reference13 articles.
1. (−)-Deprenyl leads to prolongation of L-dopa efficacy in Parkinson's disease;Birkmayer;Mod. Probl. Pharmacopsychiat.,1983
2. Inhibition of dopamine uptake by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a cause of parkinsonism;Denton;Biochem. Biophys. Res. Commun.,1984
3. Neurochemical and histochemical characterization of neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurons in the mouse;Hallman;J. Neurochem.,1985
4. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice;Heikkilla;Science,1984
5. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors;Heikkilla;Nature,1984
Cited by
68 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献